Abstract: The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

Abstract: The present invention can permit a communications request initiator to control pre-communications interactions. For example, the present invention can permit a communications request initiator to instruct a recipient communications device to present specific information to a communications request recipient when the initiator sends the communications request to the recipient. The present invention also can permit a communications request initiator to control the information presented to the initiator when he is waiting for a communications request recipient to respond to the communications request.